Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvectis Pharma, Inc.

8.85
+0.50005.99%
Post-market: 8.850.00000.00%17:59 EDT
Volume:120.74K
Turnover:1.05M
Market Cap:207.01M
PE:-7.97
High:8.99
Open:8.48
Low:8.25
Close:8.35
Loading ...

Nuvectis Pharma 2.7M share Spot Secondary priced at $5.00

TIPRANKS
·
05 Feb

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Inc - Prices Public Offering of 2.7 Mln Shares at $5.00/Share

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Inc: Commenced an Underwritten Public Offering of Its Common Stock

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
05 Feb

Insiders hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently

Simply Wall St.
·
04 Jan

Great week for Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders who have 63% stake and they haven’t stopped buying

Simply Wall St.
·
29 Dec 2024

Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium

GlobeNewswire
·
10 Dec 2024

Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks
·
25 Nov 2024

Nuvectis Pharma reports data from Phase 1b study of NXP800

TipRanks
·
15 Nov 2024

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug

Benzinga
·
15 Nov 2024

Positive Outlook for Nuvectis Pharma: Promising Clinical and Preclinical Developments Justify Buy Rating

TIPRANKS
·
14 Nov 2024

Nuvectis Pharma Stock Plummets on Updated Data for Ovarian Cancer Study

Dow Jones
·
14 Nov 2024

US Stocks Edge Lower; Cisco Earnings Top Views

Benzinga
·
14 Nov 2024

Nuvectis Pharma Inc trading resumes

TIPRANKS
·
14 Nov 2024